Mayne Pharma to invest US$65m in manufacturing expansion in North Carolina

Published: 7-Sep-2015

New facility will enhance Mayne’s development, manufacturing and packaging operations for generic and specialty drug products


Mayne Pharma will invest US$65m to significantly expand the facilities and equipment at its site in Greenville (North Carolina, USA). The company's plans include the greenfield construction of a new, 126,000 square foot, large-scale oral-dose manufacturing facility, along with the repurposing of existing space to expand contract services.

When the new facility becomes fully operational in 2018, it will more than double Mayne’s manufacturing capacity in the US. The company, which currently employs 350 people in North Carolina, anticipates hiring up to 110 more scientists, quality assurance specialists, manufacturing operators and technicians to support the expanded operations footprint.

‘Expanding our Greenville operations solidifies Mayne Pharma's aspirations in the US market, while building our talented workforce. Once operational, we can take on new and larger products, specifically those that rely on our company's drug delivery and potent handling expertise,’ said Stefan Cross, President of Mayne Pharma USA.

The new facility — which will be constructed to meet international regulatory standards — will allow Mayne to expand development, manufacturing and packaging operations for generic and specialty drug products. The increase in capacity — and the introduction of commercial-scale manufacturing of modified-release and highly potent drug products — will support on-market products, as well as a robust pipeline of products under development, enabling Mayne to become a leader globally in advanced oral drug delivery systems, Cross said.

‘Mayne Pharma has a 30-year track record of innovation and success in developing pharmaceutical products, and the company's plans to expand facilities and services in eastern North Carolina are key to its business development efforts worldwide,’ commented N.C. Governor Pat McCrory. ‘This important expansion speaks volumes about the appeal our state has for companies at every stage of their growth.’

You may also like